Vertex’s research guru has warned that it could take another 15 years to produce a suite of medicines that treat all strains of the disease, saying that a deal with the NHS will be crucial to ...

“Mathemalchemy” has been described as “a mathematics fever dream turned artistic playground for all math lovers (and haters, too).” ...

Biopharma companies require optimal clone yields to ensure maximum concentration and effectiveness of these therapeutic ...

We live in dangerous times, the security of Europe is seriously threatened, the question is now whether we will be ...

Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating ...

Buying $100 In VRTX: If an investor had bought $100 of VRTX stock 5 years ago, it would be worth $253.80 today based on a ...

Vertex Pharmaceuticals generated more than $11 billion in product revenue last year thanks to its dominance in cystic fibrosis treatment. Progress in that specialty area and two key drug approvals ...

Vertex Pharmaceuticals (VRTX) reachead $495.29 at the closing of the latest trading day, reflecting a +1.42% change compared to its last close. We recently published a list of the 11 Best Pharma ...

After hours: March 13 at 7:56:59 PM EDT Loading Chart for VTLE ...